Viewing Study NCT04614493

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:08 AM
Ignite Modification Date: 2026-05-27 @ 7:20 PM
Study NCT ID: NCT04614493
Status: UNKNOWN
Last Update Posted: 2022-03-29
First Post: 2020-10-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Initial Radiological Diagnosis Eligible for Tumor Resection View
None Initial Radiological Diagnosis Compatible With Newly Diagnosed Glioblastoma (IDH Wild-type) View
None Eligible for the Standard of Care Including Concurrent Temoradiation and … View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Primary brain cancer View
None Glioblastoma View
None first line View
None Stupp protocol View
None Ultrasounds View
None Medical device View
None SC9 View